Revolutionizing treatment with AI-powered genetic analysis for personalized care.
GeneLeap is building a platform that leverages a patient’s genetic profile to deliver tailored treatment recommendations with the goal of shifting from trial-and-error prescribing to swift, effective care, with an initial focus on Depression.
Thirty percent of depression patients have a full response to the first antidepressant they are prescribed, with less than 70% achieving remission after four lines of treatment. 1
Thirty-seven percent of depression patients experience an adverse event related to the prescription of the most common first-line therapies. 2
Potential to eliminate the typical trial-and-error process of prescribing drugs by using an individual’s genetic data to evaluate and rank treatments for optimal effectiveness.
Using generative AI, GeneLeap can model any genetic variants in any combination that impact the efficacy of antidepressants and other drugs.
GeneLeap’s proprietary drug-receptor analysis can be applied across clinical conditions from Depression to other Neurological conditions, Autoimmune and Metabolic diseases, and more.
GeneLeap’s goal is to reduce patient suffering and costs, and increase compliance, by delivering clear, actionable treatment recommendations at the outset of the treatment process.
At GeneLeap, we are developing generative AI-based methods to model interactions between drugs and their targets encoded in a patient’s genome to predict which drugs will work best for that individual. Our innovative solution provides physicians with a novel, precise way to prescribe antidepressants, giving patients a path to effective treatments sooner.
We examine an individual’s genome to model the exact proteins involved in each drug’s mechanism of action in order to rank treatment options.
We plan to validate our AI-based methods, demonstrating that they provide a more comprehensive analysis going far beyond traditional approaches.
GeneLeap’s ordering is simple, and physicians receive clear reporting that makes it easy to address patients’ treatment needs quickly and effectively.
GeneLeap is revolutionizing precision medicine by making individualized, genetics-based treatment optimization the new standard. Our innovative approach ensures that patients receive the most effective therapies tailored to their unique genetic profiles.
🔹 Empowering patients and physicians with personalized treatment solutions.
🔹 Enhancing healthcare through data-driven decision making.
🔹 Setting a new standard in precision medicine.
At newly launched GeneLeap, we are passionate about improving lives using innovations built from the latest advances in biomedical and information technologies. We focus first on patients, and their providers, to identify challenges in medicine that new science and technologies can tackle. We value the highest scientific principles, integrity, transparency and compassion–for patients, their physicians, our team and collaborators.
We are building a highly motivated team of diverse experts that share our vision and have experience introducing pioneering products into the health sciences. Please contact us to join the effort!
Read our company launch announcement from Leap AI! Learn more
We'd love to hear from you!
